These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36760590)

  • 1. Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities.
    Pan J; Li Q; Sun Y; Gu Y; Ding Y; Pang N; Zhou Y; Pei L; Gao M; Ma S; Xiao Y; Wu F; Hu D; Chen YM; Yang L
    Diabetes Metab Syndr Obes; 2023; 16():187-200. PubMed ID: 36760590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria.
    Pan J; Ding Y; Sun Y; Li Q; Wei T; Gu Y; Zhou Y; Pang N; Pei L; Ma S; Gao M; Xiao Y; Hu D; Wu F; Yang L
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease.
    Zhu C; Huang D; Ma H; Qian C; You H; Bu L; Qu S
    Front Endocrinol (Lausanne); 2022; 13():848937. PubMed ID: 35620390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
    Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
    J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
    Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology.
    Peng D; Yu Z; Wang M; Shi J; Sun L; Zhang Y; Zhao W; Chen C; Tang J; Wang C; Ni J; Wen W; Jiang J
    Front Endocrinol (Lausanne); 2022; 13():935390. PubMed ID: 35928895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Metrnl is Decreased in Metabolic Dysfunction-Associated Fatty Liver Disease: A Case-Control Study.
    Liu M; Gao X; Tian Y; Li H; Yin Z; Han L; Zhang L
    Diabetes Metab Syndr Obes; 2024; 17():533-543. PubMed ID: 38318446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum 25-hydroxy vitamin D level and metabolic associated fatty liver disease (MAFLD)-a population-based study.
    Wan B; Gao Y; Zheng Y; Chen R
    Endocr J; 2021 Jun; 68(6):631-637. PubMed ID: 33658438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.
    Dai YN; Xu CF; Pan HY; Huang HJ; Chen MJ; Li YM; Yu CH
    World J Clin Cases; 2022 May; 10(13):4097-4109. PubMed ID: 35665109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact.
    Tang SY; Tan JS; Pang XZ; Lee GH
    World J Gastroenterol; 2023 Jan; 29(3):549-560. PubMed ID: 36688021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection.
    Luo L; Ye J; Shao C; Lin Y; Sun Y; Feng S; Wang W; Zhong B
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study.
    Xie CH; Chen LW; Lin CL; Hu CC; Chien CH
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
    Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
    Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
    Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
    Front Endocrinol (Lausanne); 2022; 13():942412. PubMed ID: 36133303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease.
    Perdomo CM; Núñez-Córdoba JM; Ezponda A; Mendoza FJ; Ampuero J; Bastarrika G; Frühbeck G; Escalada J
    Front Med (Lausanne); 2022; 9():1023583. PubMed ID: 36341262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.
    van Kleef LA; Choi HSJ; Brouwer WP; Hansen BE; Patel K; de Man RA; Janssen HLA; de Knegt RJ; Sonneveld MJ
    JHEP Rep; 2021 Oct; 3(5):100350. PubMed ID: 34557660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study.
    Jiang Y; Cao H; Chen X; Yu G; Song C; Duan H; Tian F; Wan H; Shen J
    Front Public Health; 2022; 10():1022928. PubMed ID: 36388270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease.
    Huang J; Ou W; Wang M; Singh M; Liu Y; Liu S; Wu Y; Zhu Y; Kumar R; Lin S
    Risk Manag Healthc Policy; 2021; 14():491-501. PubMed ID: 33603515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: National Health and Nutrition Examination Survey 2017-2018.
    Wang X; Zhang W; Huang J; Li H; Gao J
    Front Nutr; 2023; 10():1086477. PubMed ID: 37305083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.